Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
Andrea Santamato Physical Medicine and Rehabilitation Section, “OORR Hospital,” University of Foggia, Foggia, Italy Abstract: Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard trea...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-01-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/safety-and-efficacy-of-incobotulinumtoxina-as-a-potential-treatment-fo-peer-reviewed-fulltext-article-NDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849424718810054656 |
|---|---|
| author | Santamato A |
| author_facet | Santamato A |
| author_sort | Santamato A |
| collection | DOAJ |
| description | Andrea Santamato Physical Medicine and Rehabilitation Section, “OORR Hospital,” University of Foggia, Foggia, Italy Abstract: Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard treatment for focal spasticity after stroke showing efficacy, reversibility, and low prevalence of complications. In recent years, incobotulinumtoxinA, a new Botulinum toxin type A free of complexing proteins, has been used for treating several movement disorders with safety and efficacy. IncobotulinumtoxinA is currently approved for treating spasticity of the upper limb in stroke survivors, even if several studies described the use also in lower limb muscles. In the present review article, we examine the safety and effectiveness of incobotulinumtoxinA for the treatment of spasticity after stroke. Keywords: Hypertone, botulinum toxin, incobotulinumtoxinA, onabotulinumtoxinA, abobotulinumtoxinA |
| format | Article |
| id | doaj-art-e46bd5fa879f457d8d37e4d53f003903 |
| institution | Kabale University |
| issn | 1178-2021 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Neuropsychiatric Disease and Treatment |
| spelling | doaj-art-e46bd5fa879f457d8d37e4d53f0039032025-08-20T03:30:03ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212016-01-01Volume 12Issue 125126325395Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticitySantamato A0Physical Medicine and Rehabilitation SectionAndrea Santamato Physical Medicine and Rehabilitation Section, “OORR Hospital,” University of Foggia, Foggia, Italy Abstract: Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard treatment for focal spasticity after stroke showing efficacy, reversibility, and low prevalence of complications. In recent years, incobotulinumtoxinA, a new Botulinum toxin type A free of complexing proteins, has been used for treating several movement disorders with safety and efficacy. IncobotulinumtoxinA is currently approved for treating spasticity of the upper limb in stroke survivors, even if several studies described the use also in lower limb muscles. In the present review article, we examine the safety and effectiveness of incobotulinumtoxinA for the treatment of spasticity after stroke. Keywords: Hypertone, botulinum toxin, incobotulinumtoxinA, onabotulinumtoxinA, abobotulinumtoxinAhttps://www.dovepress.com/safety-and-efficacy-of-incobotulinumtoxina-as-a-potential-treatment-fo-peer-reviewed-fulltext-article-NDTpost stroke-spasticitybotulinum toxinincobotulinumtoxinAonabotulinumtoxinAabobotulinumtoxinA |
| spellingShingle | Santamato A Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity Neuropsychiatric Disease and Treatment post stroke-spasticity botulinum toxin incobotulinumtoxinA onabotulinumtoxinA abobotulinumtoxinA |
| title | Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity |
| title_full | Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity |
| title_fullStr | Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity |
| title_full_unstemmed | Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity |
| title_short | Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity |
| title_sort | safety and efficacy of incobotulinumtoxina as a potential treatment for poststroke spasticity |
| topic | post stroke-spasticity botulinum toxin incobotulinumtoxinA onabotulinumtoxinA abobotulinumtoxinA |
| url | https://www.dovepress.com/safety-and-efficacy-of-incobotulinumtoxina-as-a-potential-treatment-fo-peer-reviewed-fulltext-article-NDT |
| work_keys_str_mv | AT santamatoa safetyandefficacyofincobotulinumtoxinaasapotentialtreatmentforpoststrokespasticity |